我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
75
9 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1909
进行中(未招募)
4
5.3%
已完成
51
68.0%
Enrolling By Invitation
1
1.3%
尚未招募
招募中
9
12.0%
Unknown
6
8.0%
暂无批准数据
- A three-month clinical trial of 80 participants demonstrated that daily 300mg bacopa supplementation improved memory, concentration, and cognitive performance compared to placebo. - Researchers found increased levels of brain cell production-associated proteins and reduced stress hormones in participants taking bacopa, suggesting potential neuroprotective benefits. - While showing promise, experts caution about bacopa's interaction with medications for dementia, glaucoma, and COPD, as well as potential digestive side effects.